Centauri Therapeutics Limited
PrivateLast Round
Series A
Feb 24, 2026
Total Funding Raised
$87.3M
Momentum Score
25 /100
Company Overview
Centauri Therapeutics Limited is a biotechnology company that develops immunotherapies for infectious diseases and oncology using its proprietary Alphamer platform technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Centauri Therapeutics Limited Comps
Public and private peers based on sector, stage, and business model.
Centauri Therapeutics Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 24, 2026 | ||||
| Grant | Jul 29, 2025 | ||||
| Grant | Nov 25, 2024 | ||||
| Grant | Feb 22, 2022 | ||||
| Series A | Feb 16, 2022 | ||||
Grant | Jan 7, 2020 |
Key People
Founding team and executive leadership
Centauri Therapeutics Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| REPAIR Impact Fund | Series A |
| AMR Action Fund | Series A |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Series A, Grant |
| Boehringer Ingelheim Venture Fund | Series A |
| Innovate UK | Grant |
| Medicines Discovery Catapult | Grant |
Centauri Therapeutics Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Centauri Therapeutics Limited's valuation, stock price, and market status.
